NO308302B1 - Tetrahydropyranderivativer, farmasøytisk preparat inneholdende slike derivater samt anvendelse derav - Google Patents

Tetrahydropyranderivativer, farmasøytisk preparat inneholdende slike derivater samt anvendelse derav

Info

Publication number
NO308302B1
NO308302B1 NO941936A NO941936A NO308302B1 NO 308302 B1 NO308302 B1 NO 308302B1 NO 941936 A NO941936 A NO 941936A NO 941936 A NO941936 A NO 941936A NO 308302 B1 NO308302 B1 NO 308302B1
Authority
NO
Norway
Prior art keywords
derivatives
pharmaceutical preparations
preparations containing
tetrahydropyran
hydroxy groups
Prior art date
Application number
NO941936A
Other languages
English (en)
Other versions
NO941936D0 (no
NO941936L (no
Inventor
A R C Murty Bulusu
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939310975A external-priority patent/GB9310975D0/en
Priority claimed from GB939310969A external-priority patent/GB9310969D0/en
Priority claimed from GB939312590A external-priority patent/GB9312590D0/en
Priority claimed from GB939313553A external-priority patent/GB9313553D0/en
Priority claimed from GB939319618A external-priority patent/GB9319618D0/en
Priority claimed from GB939319617A external-priority patent/GB9319617D0/en
Priority claimed from GB939326045A external-priority patent/GB9326045D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO941936D0 publication Critical patent/NO941936D0/no
Publication of NO941936L publication Critical patent/NO941936L/no
Publication of NO308302B1 publication Critical patent/NO308302B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Seasonings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Color Printing (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO941936A 1993-05-27 1994-05-25 Tetrahydropyranderivativer, farmasøytisk preparat inneholdende slike derivater samt anvendelse derav NO308302B1 (no)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB939310975A GB9310975D0 (en) 1993-05-27 1993-05-27 Organic compounds
GB939310969A GB9310969D0 (en) 1993-05-27 1993-05-27 Organic compounds
GB939312590A GB9312590D0 (en) 1993-06-18 1993-06-18 Organic compounds
GB939313553A GB9313553D0 (en) 1993-07-01 1993-07-01 Organic compounds
GB939319618A GB9319618D0 (en) 1993-09-23 1993-09-23 Organic compounds
GB939319617A GB9319617D0 (en) 1993-09-23 1993-09-23 Organic compounds
GB939326045A GB9326045D0 (en) 1993-12-21 1993-12-21 Organic compounds

Publications (3)

Publication Number Publication Date
NO941936D0 NO941936D0 (no) 1994-05-25
NO941936L NO941936L (no) 1994-11-28
NO308302B1 true NO308302B1 (no) 2000-08-28

Family

ID=27562893

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941936A NO308302B1 (no) 1993-05-27 1994-05-25 Tetrahydropyranderivativer, farmasøytisk preparat inneholdende slike derivater samt anvendelse derav

Country Status (24)

Country Link
US (1) US5493019A (no)
EP (1) EP0626385B1 (no)
JP (1) JP3076724B2 (no)
CN (1) CN1048495C (no)
AT (1) ATE252105T1 (no)
AU (1) AU682499B2 (no)
CA (1) CA2124260C (no)
CY (1) CY2523B1 (no)
CZ (1) CZ286157B6 (no)
DE (1) DE69433234T2 (no)
DK (1) DK0626385T3 (no)
ES (1) ES2208651T3 (no)
FI (1) FI107159B (no)
HK (1) HK1011684A1 (no)
HU (1) HU218919B (no)
IL (1) IL109775A (no)
MY (1) MY110603A (no)
NO (1) NO308302B1 (no)
NZ (1) NZ260596A (no)
PH (1) PH30420A (no)
PT (1) PT626385E (no)
RU (1) RU2130460C1 (no)
SI (1) SI0626385T1 (no)
SK (1) SK281541B6 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100335063C (zh) 1994-10-26 2007-09-05 诺瓦蒂斯有限公司 药物组合物
JP2001520170A (ja) 1997-10-16 2001-10-30 ボード・オヴ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム Ｎｆ−ａｔ３機能に関連した心肥大動物モデルと治療法
ME00189B (me) 1998-03-26 2011-02-10 Astellas Pharma Inc Preparati sa neprekidnim oslobađanjem
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
US6307049B1 (en) 1998-09-30 2001-10-23 The Procter & Gamble Co. Heterocyclic 2-substituted ketoamides
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
US6121257A (en) * 1999-03-31 2000-09-19 Abbott Laboratories Sulfamate containing macrocyclic immunomodulators
US7063857B1 (en) 1999-04-30 2006-06-20 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
AU2003254566A1 (en) 2002-07-23 2004-02-09 Novartis Ag Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
JP2007516951A (ja) * 2003-12-30 2007-06-28 アステラス製薬株式会社 気道閉塞症の治療または予防のためのマクロライドの使用
GT200500282A (es) 2004-10-12 2006-05-04 Heteroatomos conteniendo compuestos triciclicos.
EP1688161A1 (en) * 2004-11-02 2006-08-09 Switch Biotech Aktiengesellschaft Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis
WO2011008172A1 (en) * 2009-07-15 2011-01-20 S*Bio Pte Ltd 9e-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza- tetracyclo[18.3.1.1(2,5).1(14)18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt
CN107106588B (zh) 2014-10-28 2020-08-11 山口晃史 用于改善妊娠状态的药剂及其使用
AU2019318035A1 (en) 2018-08-10 2021-03-04 Koushi Yamaguchi Therapeutic agent for humoral immunity-related diseases in materno-fetal relationship
CA3123535A1 (en) 2018-12-18 2020-06-25 Koushi Yamaguchi Agent for improving infertility, recurrent miscarriage, and state of pregnancy
JP2022518555A (ja) * 2019-01-23 2022-03-15 ザ・ジョンズ・ホプキンス・ユニバーシティ 非免疫抑制性ｆｋ５０６類似体およびその使用
WO2022139524A1 (ko) * 2020-12-24 2022-06-30 서울대학교산학협력단 신규 fk506 유도체 및 이를 포함하는 발모 촉진용 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0078235A3 (de) * 1981-10-23 1983-06-29 Ciba-Geigy Ag Dihalogenierte Steroide
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
CH677448A5 (no) * 1987-11-09 1991-05-31 Sandoz Ag
EP0385936A1 (de) * 1989-02-27 1990-09-05 Ciba-Geigy Ag Peptidlacton und derivate davon, Verfahren zu ihrer Herstellung und Mittel zur Ausführung des Verfahrens
IE910847A1 (en) * 1990-03-13 1991-09-25 Fisons Plc Immunosuppressive macrocyclic compounds
CA2051872A1 (en) * 1990-09-24 1992-03-25 Kevin M. Byrne Directed biosynthesis process for prolyl-immunomycin
GB2249787A (en) * 1990-11-19 1992-05-20 Fujisawa Pharmaceutical Co Lactone compounds
WO1992013862A1 (en) * 1991-02-05 1992-08-20 Fujisawa Pharmaceutical Co., Ltd. Lactone compounds
JP3036923B2 (ja) * 1991-10-28 2000-04-24 理化学研究所 デプシペプチドａ、ｂその製造方法、並びに抗ウイルス剤及び抗菌剤
HUT66531A (en) * 1992-05-07 1994-12-28 Sandoz Ag Heteroatoms-containing tricyclic compounds, pharmaceutical prepns contg. them and process for producing them

Also Published As

Publication number Publication date
MY110603A (en) 1998-08-29
CA2124260C (en) 2007-04-17
FI942444A0 (fi) 1994-05-25
SK281541B6 (sk) 2001-04-09
HU9401582D0 (en) 1994-08-29
SI0626385T1 (en) 2004-02-29
NO941936D0 (no) 1994-05-25
CZ286157B6 (cs) 2000-01-12
HUT71396A (en) 1995-11-28
CN1099756A (zh) 1995-03-08
EP0626385B1 (en) 2003-10-15
US5493019A (en) 1996-02-20
ATE252105T1 (de) 2003-11-15
AU6331794A (en) 1994-12-01
CN1048495C (zh) 2000-01-19
FI107159B (fi) 2001-06-15
FI942444A (fi) 1994-11-28
CZ129594A3 (en) 1995-01-18
JP3076724B2 (ja) 2000-08-14
RU2130460C1 (ru) 1999-05-20
NZ260596A (en) 1995-10-26
DE69433234D1 (de) 2003-11-20
HU218919B (hu) 2000-12-28
AU682499B2 (en) 1997-10-09
SK61194A3 (en) 1995-02-08
JPH06340672A (ja) 1994-12-13
PH30420A (en) 1997-05-09
DK0626385T3 (da) 2004-02-16
CA2124260A1 (en) 1994-11-28
DE69433234T2 (de) 2004-08-05
EP0626385A1 (en) 1994-11-30
ES2208651T3 (es) 2004-06-16
IL109775A0 (en) 1994-08-26
CY2523B1 (en) 2006-02-08
HK1011684A1 (en) 1999-07-16
NO941936L (no) 1994-11-28
IL109775A (en) 1999-07-14
PT626385E (pt) 2004-03-31

Similar Documents

Publication Publication Date Title
CY2523B1 (en) Tetrahydropyran derivatives
PL300068A1 (en) 9-(substituted glycil) amido-6-demethyl-6-deoxytetracyclines, methods of obtaining such compounds as well as their organic and inorganic salts or metal complexes, pharmaceutical agent and veterinari agent
ES2111769T3 (es) Nuevos usos de il-10.
DE60228761D1 (de) Pharmazeutische zusammensetzung (kit) enthaltend dihydropyridinonverbindungen und eine verbindung mit immunmodulatorischer (oder antiinflammatorischer) wirkung und ihre verwendung
RU94018524A (ru) Производные тетрагидропирана, способ их получения и фармацевтическая композиция на их основе
NO308607B1 (no) Kjemisk forbindelse, et farmasøytisk preparat inneholdende denne, samt anvendelse av forbindelsen til fremstilling av en blodplateaggregeringsinhibiotor og fremstilling av et farmasøytisk preparat til behandling eller forebygging av trombotiske
IL105607A0 (en) Heteroatoms-containing tricyclic compounds,their preparation and pharmaceutical compositions containing them
AU2008995A (en) Improvements in or relating to organic compounds
NO178540C (no) Bisfenyletanderivater, farmasöytisk preparat derav samt anvendelse
ITMI911343A0 (it) Composizioni farmaceutiche per il trattamento di dermatosi

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees